Multi-Ingredient Preworkout Supplement on Peak Torque and Muscle Activation During Fatigue

NCT ID: NCT07217210

Last Updated: 2025-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-15

Study Completion Date

2022-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of the present study was to examine the acute effects of a MIPS product on peak torque production of the leg extensors during a fatiguing isokinetic protocol involving isometric, concentric, and eccentric muscle actions. In addition, we investigated the effects of the MIPS supplement on EMG amplitude and median power frequency (MDF) responses from the vastus lateralis, rectus femoris, and vastus medi-alis muscles.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the past several years, the use of multi-ingredient pre-workout supplements (MIPS) has become extremely popularized, and their ergogenic potential has become well-established for various sports and within the general population by both competi-tive and recreational athletes \[1-6\]. Some of the more prevalent ingredients in MIPS in-clude caffeine, β-alanine, L-citrulline, L-arginine, and creatine, with many of these in-gredients and others often combined into proprietary blends \[7\]. Although recent find-ings indicate synergistic effects among these ingredients may be present \[8\], it has been suggested that caffeine is the predominant factor responsible for the acute ergogenic effects associated with MIPS \[2,9\]. In fact, the recommended timing for ingestion of most MIPS is likely based on the stimulating effects of caffeine which typically peaks in the bloodstream 30-60 minutes post-ingestion \[10,11\]. As a nutritional supplement, caffeine has been shown to be beneficial for maintaining maximal strength and endur-ance as well as improving time-trial performance and other forms of high-intensity ex-ercise \[10,11\]. These effects have been attributed to improved motor unit firing rates and calcium release from the sarcoplasmic reticulum, subsequently enhancing muscle contraction force \[4,12\]. β-alanine is another ingredient included in most MIPS \[7\] and has been identified as the rate-limiting precursor to carnosine, an intracellular muscle buffer \[13\]. Supplementation with β-alanine has been shown to increase intramuscular levels of carnosine, thereby attenuating metabolic acidosis during high-intensity exer-cise \[13\]. As precursors to the potent vasodilator, nitric oxide, both L-citrulline and L-arginine supplements have been demonstrated to enhance blood flow to active mus-cles, subsequently delaying the onset of muscular fatigue \[14-16\]. Based on these collec-tive physiological mechanisms, a MIPS containing these notable ergogenic ingredients (caffeine, β-alanine, L-citrulline, L-arginine) may provide neuromuscular benefits for sustaining force or power output during various forms of vigorous activity.

The vast majority of previous investigations examining the acute effects of MIPS on performance have focused on isotonic variables of upper and lower body muscular strength \[i.e. bench press, leg press, and squat one-repetition maximum (1-RM), maxi-mum voluntary contractions (MVC)\], endurance (i.e. repetitions to failure at %1-RM), and power (vertical jump, Wingate Anaerobic testing, and critical power) \[1-6,9,12,18,19\]. Despite conflicting evidence for maximal force and power production \[4,6,20,21\], the findings of several studies \[1,3,4,12,17-19,22,23\] have largely indicated acute MIPS supplementation can enhance overall force retention and muscular endur-ance during prolonged or intermittent bouts of high intensity activity. Currently, how-ever, the exact underlying mechanisms responsible for these benefits on neuromuscular function are poorly understood.

Isokinetic dynamometers coupled with surface electromyography (EMG) record-ings are two frequently utilized instruments for the non-invasive assessment of neu-romuscular function and fatigue during static and dynamic muscle actions \[24-27\]. The utility of isokinetic testing involves the ability to measure isometric, concentric, and eccentric torque levels across an entire range of motion at controlled velocities with minimal skill involvement required. Results from isokinetic testing can provide torque production at different joint angles, while identifying muscle imbalances, tracking the recovery process from injury or surgery, and measuring the rate of force development \[28,29\]. Thus, as both a training and assessment tool, isokinetic testing is common in clinical and performance settings.

Surface electromyography (EMG) is a technique that involves recording and quantifying the action potentials associated with contracting skeletal muscle fibers \[30\]. The amplitude contents of the EMG signal reflect the level of muscle activation (i.e. motor unit recruitment and firing rates) \[31\], whereas the frequency contents pro-vide information related to the muscle fiber conduction velocity \[32\]. To our knowledge, only one study \[5\] has directly examined EMG responses associated with acute MIPS administration. Specifically, Negro et al. \[5\] reported acute MIPS (creatine, arginine, β-alanine, glutamine, taurine) ingestion improved EMG-based indicators of fatigue (i.e. conduction velocity, fractal dimension) during sustained isometric contrac-tions following a resistance exercise protocol designed to elicit fatigue. The authors \[5\] proposed these acute benefits of their MIPS product may be attributable to improved: 1) peripheral components of performance fatiguability, 2) buffering capacity of the mus-cle from β-alanine, and 3) regulation of mechanisms associated with exercise-induced fatigue from arginine, glutamine, and taurine. Based on these findings \[5\], valuable in-sight can be gained into the underlying neuromuscular factors associated with MIPS ingestion by examining muscle function and fatigue through isokinetic and EMG as-sessments. Thus, the primary purpose of the present study was to examine the acute ef-fects of a MIPS product on peak torque production of the leg extensors during a fatigu-ing isokinetic protocol involving isometric, concentric, and eccentric muscle actions. In addition, we investigated the effects of the MIPS supplement on EMG amplitude and median power frequency (MDF) responses from the vastus lateralis, rectus femoris, and vastus medialis muscles.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Adult Male

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Within-subjects, placebo-controlled, crossover design
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supplement group

Multi-ingredient preworkout supplement

Group Type EXPERIMENTAL

Multi-ingredient preworkout supplement

Intervention Type DIETARY_SUPPLEMENT

Experimental supplement.

Placebo group

Microcystalline cellulose

Group Type PLACEBO_COMPARATOR

Multi-ingredient preworkout supplement

Intervention Type DIETARY_SUPPLEMENT

Experimental supplement.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multi-ingredient preworkout supplement

Experimental supplement.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male, 19-29 years of age, one year of resistance training experience

Exclusion Criteria

* Subjects were eligible to participate if they did not report: 1) cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders; 2) use of any medications; 3) use of nutritional supplements; 4) habitual use of caffeine (≥ 1 caffeinated beverage per day); or 5) participation in another clinical trial or investigation of another nutritional product within 30 days of screening/enrollment.
Minimum Eligible Age

19 Years

Maximum Eligible Age

29 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northern Illinois University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clayton Camic, PHD

Role: PRINCIPAL_INVESTIGATOR

Northern Illinois University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northern Illinois University

DeKalb, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

#HS22-0139

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Training Intrinsic Foot Muscles
NCT03670563 COMPLETED NA
Strength Training and Muscle Lipids
NCT06480747 COMPLETED NA